Abstract
29P - Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have